Literature DB >> 17947537

Two functionally linked amino acids in the stem 2 region of measles virus haemagglutinin determine infectivity and virulence in the rodent central nervous system.

K Moeller-Ehrlich1, M Ludlow, R Beschorner, R Meyermann, B K Rima, W P Duprex, S Niewiesk, J Schneider-Schaulies.   

Abstract

Rodent brain-adapted measles virus (MV) strains, such as CAM/RB and recombinant MVs based on the Edmonston strain containing the haemagglutinin (H) of CAM/RB, cause acute encephalitis after intracerebral infection of newborn rodents. We have demonstrated that rodent neurovirulence is modulated by two mutations at amino acid positions 195 and 200 in the H protein, one of these positions (200) being a potential glycosylation site. In order to analyse the effects of specific amino acids at these positions, we introduced a range of individual and combined mutations into the open reading frame of the H gene to generate a number of eukaryotic expression plasmids. The functionality of the mutant H proteins was assessed in transfected cells and by generating recombinant viruses. Interestingly, viruses caused acute encephalitis only if the amino acid Ser at position 200 was coupled with Gly at position 195, whereas viruses with single or combined mutations at these positions, including glycosylation at position 200, were attenuated. Neurovirulence was associated with virus spread and induction of neuronal apoptosis, whereas attenuated viruses failed to infect brain cells. Similar results were obtained by using primary brain-cell cultures. Our findings indicate that a structural alteration in the stem 2 region of the H protein at position 195 or 200 interferes with infectivity of rodent neurons, and suggest that the interaction of the viral attachment protein with cellular receptors on neurons is affected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947537     DOI: 10.1099/vir.0.83235-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

2.  The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence.

Authors:  Minoru Ayata; Kaoru Takeuchi; Makoto Takeda; Shinji Ohgimoto; Seiichi Kato; Luna Bhatta Sharma; Miyuu Tanaka; Mitsuru Kuwamura; Hiroshi Ishida; Hisashi Ogura
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

Review 3.  Making it to the synapse: measles virus spread in and among neurons.

Authors:  V A Young; G F Rall
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 4.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

5.  Foxp3+ regulatory T cells control persistence of viral CNS infection.

Authors:  Dajana Reuter; Tim Sparwasser; Thomas Hünig; Jürgen Schneider-Schaulies
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

Review 6.  Measles Encephalitis: Towards New Therapeutics.

Authors:  Marion Ferren; Branka Horvat; Cyrille Mathieu
Journal:  Viruses       Date:  2019-11-02       Impact factor: 5.048

7.  Mutated Measles Virus Matrix and Fusion Protein Influence Viral Titer In Vitro and Neuro-Invasion in Lewis Rat Brain Slice Cultures.

Authors:  Johannes Busch; Soroth Chey; Michael Sieg; Thomas W Vahlenkamp; Uwe G Liebert
Journal:  Viruses       Date:  2021-04-01       Impact factor: 5.048

8.  The Asia 2 specific signal peptide region and other domains in fusion protein genes characterized Asia 1 and Asia 2 canine distemper viruses.

Authors:  Serageldeen Sultan; Nataya Charoenvisal; Nguyen Thi Lan; Ryoji Yamaguchi; Ken Maeda; Kazushige Kai
Journal:  Virol J       Date:  2009-10-06       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.